Quick links

Showcase Innovations

Tracheal transplant »

ID5: Distribute the Product

Until now, transplants of the airways have not been performed because they would require the use of huge doses of immunosuppressive drugs. However, this pioneering procedure used tissue-engineering techniques to develop a biologically-treated organ with which surgeons were able to replace a damaged bronchus without the need for immunosuppressive medication.

View project
Owner:
Robert Chesters

Zilico Non Invasive Cancer Diagnostic »

ID5: Distribute the Product

A portable diagnostic device able to differentiate between healthy, pre-malignant and abnormal cells has been developed to provide superior performance over existing diagnostic procedures in the detection and treatment of cervical cancer. Based on electrical impedance spectroscopy, the device has undergone extensive testing and evaluation on nearly 1,000 patients in a number of clinical trials, all subject to peer reviewed publications and presented at key scientific meetings. Results from the latest multi-centre trial are forming part of the submission for regulatory approval with a view to the first product being launched in Q1 of 2013.

View project
Owner:
Robert Chesters

PainKwell »

ID5: Distribute the Product

A low cost ambulatory acute pain management system that has proven to relieve postoperative pain for patients following several types of surgery, especially hip and knee replacement. Using patent pending components it is a proven, safer means of avoiding wound infection, faster surgical application and a key factor in patient enhanced recovery programmes whilst reducing the use of opiates.

View project
Owner:
Peter Taylor

RehabAngel »

ID5: Distribute the Product

The RehabAngel is a unique variable incline device that provides control and safety for patients requiring lower limb exercises.

View project
Owner:
Robert Chesters
Tags:
Rehabilitation , Physiotherapy

GraftBolt »

ID5: Distribute the Product

A new ACL tibial fixation device (GraftBolt®) was developed by an NHS surgeon at the University Hospital of South Manchester NHS Foundation Trust in collaboration with University of Manchester mechanical engineers. TrusTECH (NHS Innovation Hub for the North West) and the University funded the initial development work, testing and patent filing. Arthrex was granted a licence to manufacture and sell the device. GraftBolt® was placed on the market by Arthrex in 2010.

View project
Owner:
Robert Chesters